How to Prioritize the Many Therapeutic Options for HER2+ Metastatic Breast Cancer

Debasish Tripathy, MD identifies the latest therapeutic options for HER2+ metastatic breast cancer and provides treatments for the advanced disease.

Back to Symposium Page »


March 20, 2021

Created by

Scripps CME Connection

Related Presenters

Debasish Tripathy, MD

Debasish Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
MD Anderson Cancer Center, University of Texas

Dr. Debu Tripathy is Professor of Medicine and Chair, Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center.  His clinical research focuses on the evaluation and development of novel therapeutics in ...

View full profile